ITC-Measured Tail Fiber RBD Accessibility Score as a Phage Engineering Criterion for Designing Neutralization-Resistant Receptor-Binding Domains

Phage therapy uses viruses called bacteriophages — or just 'phages' — to kill dangerous bacterial infections that antibiotics can't handle. It sounds futuristic, but it's already being used in desperate cases. The catch? Our immune system eventually notices the phages and builds antibodies against them, neutralizing the treatment within a week or two. This hypothesis proposes a clever strategy borrowed from HIV research to engineer phages that can slip past those antibodies. The key tool is isothermal titration calorimetry, or ITC — essentially a super-sensitive thermometer that measures the tiny amounts of heat released when two molecules stick together. Researchers would use ITC to systematically test mutations on the 'landing tip' of a phage (the part that grabs onto bacteria) to find a sweet spot: mutations that break the antibody's grip on the phage while leaving the phage's ability to latch onto its bacterial target completely intact. It's like finding a disguise that fools your immune system but doesn't interfere with the phage doing its job. The same logic was used to understand how HIV mutates to evade immune responses, and this hypothesis asks whether that blueprint can be transplanted into phage engineering. What makes this particularly interesting is the precision of the approach. Rather than randomly mutating phages and hoping for the best, scientists would build a detailed map — a two-dimensional landscape — showing exactly which tweaks cause immune evasion versus which ones wreck the phage's function. Positions that sit in the 'escape without receptor loss' zone become prime engineering targets. It's systematic, rational design rather than trial and error.

This is an AI-generated summary. Read the full mechanism below for technical detail.